Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Dirk Schriefer, Rocco Haase, Nils-Henning Ness & Tjalf Ziemssen. (2022) Cost of illness in multiple sclerosis by disease characteristics – A review of reviews. Expert Review of Pharmacoeconomics & Outcomes Research 22:2, pages 177-195.
Read now
Read now
Kaoru Yamabe, Marco D DiBonaventura & Chris L Pashos. (2019) Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries. ClinicoEconomics and Outcomes Research 11, pages 61-71.
Read now
Read now
Gabriel Adelman, Stanley G. Rane & Kathleen F. Villa. (2013) The cost burden of multiple sclerosis in the United States: a systematic review of the literature. Journal of Medical Economics 16:5, pages 639-647.
Read now
Read now
Krithika Rajagopalan, Richard A. Brook, Ian A. Beren & Nathan L. Kleinman. (2011) Comparing costs and absences for multiple sclerosis among US employees: pre- and post-treatment initiation. Current Medical Research and Opinion 27:1, pages 179-188.
Read now
Read now
Nathan L. Kleinman, Ian A. Beren, Krithika Rajagopalan & Richard A. Brook. (2010) Medication adherence with disease modifying treatments for multiple sclerosis among US employees. Journal of Medical Economics 13:4, pages 633-640.
Read now
Read now
Articles from other publishers (6)
Richard A Brook, Nathan L Kleinman & Ian A Beren. (2021) Rheumatoid Arthritis Disability and Absence Trends in the United States. Journal of Biomedical Research & Environmental Sciences 2:12, pages 1238-1245.
Crossref
Crossref
Shaloo Gupta, Amir Goren, Amy L Phillips, Fernando Dangond & Michelle Stewart. (2014) Self-reported severity among patients with multiple sclerosis in the U.S. and its association with health outcomes. Multiple Sclerosis and Related Disorders 3:1, pages 78-88.
Crossref
Crossref
Nathan L. Kleinman, Mary A. Cifaldi, James E. Smeeding, James W. Shaw & Richard A. Brook. (2013) Annual Incremental Health Benefit Costs and Absenteeism Among Employees With and Without Rheumatoid Arthritis. Journal of Occupational & Environmental Medicine 55:3, pages 240-244.
Crossref
Crossref
Nathan L. Kleinman, Nicholas J. Rohrbacker, Sarah A. White, Jamie L. March & Matthew R. Reynolds. (2011) Economic Impact to Employers of Treatment Options for Cardiac Arrhythmias in the US Health System. Journal of Occupational & Environmental Medicine 53:4, pages 405-414.
Crossref
Crossref
Richard A. Brook, Nathan L. Kleinman, Rok Seon Choung, Arthur K. Melkonian, James E. Smeeding & Nicholas J. Talley. (2010) Functional Dyspepsia Impacts Absenteeism and Direct and Indirect Costs. Clinical Gastroenterology and Hepatology 8:6, pages 498-503.
Crossref
Crossref
Nicholas J. Rohrbacker, Nathan L. Kleinman, Sarah A. White, Jamie L. March & Matthew R. Reynolds. (2010) The Burden of Atrial Fibrillation and Other Cardiac Arrhythmias in an Employed Population: Associated Costs, Absences, and Objective Productivity Loss. Journal of Occupational & Environmental Medicine 52:4, pages 383-391.
Crossref
Crossref